Antibiotice Statistics

Total Valuation

Antibiotice has a market cap or net worth of RON 2.18 billion. The enterprise value is 2.23 billion.

Market Cap	2.18B
Enterprise Value	2.23B

Important Dates

The next estimated earnings date is Friday, November 15, 2024.

Earnings Date	Nov 15, 2024
Ex-Dividend Date	Sep 23, 2024

Share Statistics

Antibiotice has 671.34 million shares outstanding. The number of shares has increased by 0.03% in one year.

Shares Outstanding	671.34M
Shares Change (YoY)	+0.03%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.00%
Owned by Institutions (%)	0.16%
Float	117.94M

Valuation Ratios

The trailing PE ratio is 23.32.

PE Ratio	23.32
Forward PE	n/a
PS Ratio	3.34
PB Ratio	2.51
P/FCF Ratio	48.12
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.19, with an EV/FCF ratio of 49.40.

EV / Earnings	23.94
EV / Sales	3.43
EV / EBITDA	16.19
EV / EBIT	21.93
EV / FCF	49.40

Financial Position

The company has a current ratio of 2.13, with a Debt / Equity ratio of 0.14.

Current Ratio	2.13
Quick Ratio	1.37
Debt / Equity	0.14
Debt / EBITDA	0.86
Debt / FCF	2.62
Interest Coverage	25.38

Financial Efficiency

Return on equity (ROE) is 11.86% and return on invested capital (ROIC) is 7.17%.

Return on Equity (ROE)	11.86%
Return on Assets (ROA)	5.74%
Return on Capital (ROIC)	7.17%
Revenue Per Employee	481,288
Profits Per Employee	68,994
Employee Count	1,352
Asset Turnover	0.59
Inventory Turnover	1.41

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +180.51% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+180.51%
50-Day Moving Average	2.99
200-Day Moving Average	2.26
Relative Strength Index (RSI)	60.40
Average Volume (20 Days)	212,526

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Antibiotice had revenue of RON 650.70 million and earned 93.28 million in profits. Earnings per share was 0.14.

Revenue	650.70M
Gross Profit	410.42M
Operating Income	101.81M
Pretax Income	97.38M
Net Income	93.28M
EBITDA	137.89M
EBIT	101.81M
Earnings Per Share (EPS)	0.14

Full Income Statement

Balance Sheet

The company has 60.75 million in cash and 118.43 million in debt, giving a net cash position of -57.68 million or -0.09 per share.

Cash & Cash Equivalents	60.75M
Total Debt	118.43M
Net Cash	-57.68M
Net Cash Per Share	-0.09
Equity (Book Value)	865.49M
Book Value Per Share	1.29
Working Capital	272.11M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 160.94 million and capital expenditures -115.74 million, giving a free cash flow of 45.20 million.

Operating Cash Flow	160.94M
Capital Expenditures	-115.74M
Free Cash Flow	45.20M
FCF Per Share	0.07

Full Cash Flow Statement

Margins

Gross margin is 63.07%, with operating and profit margins of 15.65% and 14.34%.

Gross Margin	63.07%
Operating Margin	15.65%
Pretax Margin	14.97%
Profit Margin	14.34%
EBITDA Margin	21.19%
EBIT Margin	15.65%
FCF Margin	6.95%

Dividends & Yields

This stock pays an annual dividend of 0.08, which amounts to a dividend yield of 2.51%.

Dividend Per Share	0.08
Dividend Yield	2.51%
Dividend Growth (YoY)	946.97%
Years of Dividend Growth	1
Payout Ratio	3.94%
Buyback Yield	-0.03%
Shareholder Yield	2.47%
Earnings Yield	4.29%
FCF Yield	2.08%

Dividend Details

Stock Splits

The last stock split was on May 13, 2013. It was a forward split with a ratio of 1.1819213313.

Last Split Date	May 13, 2013
Split Type	Forward
Split Ratio	1.1819213313

Scores

Antibiotice has an Altman Z-Score of 3.18.

Altman Z-Score	3.18
Piotroski F-Score	n/a